Indication:
- Adjuvant Therapy
- First-line treatment for metastatic NSCLC
- Previously treated metastatic NSCLC
Strength:
- 80mg Tablet
Tagrix
- Generic Name: Osimertinib 80mg
- Therapeutic Segment: Kinase Inhibitors
Indication:
Strength:
© Copyrights 2024 All Rights Reserved. Himmel Pharma
